arXiv:2605.27082v1 Announce Type: new Abstract: Biomedical discovery often requires connecting broad biomedical knowledge with specific experimental or clinical data. Background knowledge suggests relevant mechanisms but is usually too general to map directly onto dataset variables, while data-driven patterns can be dataset-specific and hard to interpret mechanistically. We study this missing link as knowledge contextualization: transforming broad biomedical knowledge into evidence-supported, scenario-grounded propositions that domain experts can inspect, replay, and validate. We propose SCENE
The proliferation of broad biomedical knowledge coupled with advancements in AI now enables sophisticated contextualization methods.
This development allows for more precise and actionable insights from complex biomedical data, accelerating drug discovery and personalized medicine.
The ability to translate general biomedical knowledge into scenario-specific, evidence-supported propositions fundamentally alters how discovery and clinical research are conducted.
- · Pharmaceutical research and development
- · Biotech companies
- · Medical AI platforms
- · Healthcare providers
- · Traditional discovery methods
- · Generic knowledge management systems
AI systems will become more adept at generating testable hypotheses grounded in specific patient contexts.
This will lead to a significant acceleration in the development of targeted therapies and diagnostics.
The democratization of advanced biomedical insight could shift power dynamics within the healthcare and pharmaceutical industries.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.AI